Доступ предоставлен для: Guest
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции
Critical Reviews™ in Immunology
Импакт фактор: 1.352 5-летний Импакт фактор: 3.347 SJR: 1.022 SNIP: 0.55 CiteScore™: 2.19

ISSN Печать: 1040-8401
ISSN Онлайн: 2162-6472

Выпуски:
Том 39, 2019 Том 38, 2018 Том 37, 2017 Том 36, 2016 Том 35, 2015 Том 34, 2014 Том 33, 2013 Том 32, 2012 Том 31, 2011 Том 30, 2010 Том 29, 2009 Том 28, 2008 Том 27, 2007 Том 26, 2006 Том 25, 2005 Том 24, 2004 Том 23, 2003 Том 22, 2002 Том 21, 2001 Том 20, 2000 Том 19, 1999 Том 18, 1998 Том 17, 1997 Том 16, 1996 Том 15, 1995 Том 14, 1994

Critical Reviews™ in Immunology

Купить выпуск $396.00 Том 21, 2001 Выпуск 1-3

DOI: 10.1615/CritRevImmunol.v21.i1-3

Содержание:

A Nondeletional Mechanism for Central T-Cell Tolerance
Robert L. Rubin, Anke Kretz-Rommel
12 pages
DOI: 10.1615/CritRevImmunol.v21.i1-3.20
T-Cell Receptor-Derived Peptides in Immunoregulation and Therapy of Retrovirally Induced Immunosuppression
John J. Marchalonis, Ian F. Robey, Allen B. Edmundson, R. Tomas Sepulveda, Ronald R. Watson
18 pages
DOI: 10.1615/CritRevImmunol.v21.i1-3.40
Induction and Direction of Immune Responses by Vaccine Adjuvants
Virgil E. J. C. Schijns
11 pages
DOI: 10.1615/CritRevImmunol.v21.i1-3.50
The Basis of Immunogenicity of Endocrine Allografts
Mark R. Nicolls, Marilyne Coulombe, Ronald G. Gill
15 pages
DOI: 10.1615/CritRevImmunol.v21.i1-3.60
The Potential of CpG Oligodeoxynucleotides as Mucosal Adjuvants
Risini D. Weeratna, Paul J. Payette, Heather L. Davis
18 pages
DOI: 10.1615/CritRevImmunol.v21.i1-3.70
Peripheral Nonresponsiveness to Orally Administered Soluble Protein Antigens
Cathryn Nagler-Anderson, Hai Ning Shi
11 pages
DOI: 10.1615/CritRevImmunol.v21.i1-3.80
Dendritic Cells in Cancer Immunotherapy
Matthias Gunzer, Stephan Grabbe
13 pages
DOI: 10.1615/CritRevImmunol.v21.i1-3.90
Therapeutic Potential of Leukemia-Derived Dendritic Cells: Preclinical and Clinical Progress
David F. Claxton, John McMannis, Richard E. Champlin, Aniruddha Choudhury
9 pages
DOI: 10.1615/CritRevImmunol.v21.i1-3.100
Diverse Functional Activity of CD83+ Monocyte-Derived Dendritic Cells and the Implications for Cancer Vaccines
Brian J. Czerniecki, Peter A. Cohen, Mark B. Faries, Shuwen Xu, James G. Roros, Isabelle Bedrosian
22 pages
DOI: 10.1615/CritRevImmunol.v21.i1-3.110
CD14+ Monocytes as Dendritic Cell Precursors: Diverse Maturation-Inducing Pathways Lead to Common Activation of NF-kB/RelB
Gary K. Koski, Lyudmila A. Lyakh, Peter A. Cohen, Nancy R. Rice
12 pages
DOI: 10.1615/CritRevImmunol.v21.i1-3.120
The Identification and Development of Specific Monoclonal Antibodies to Squamous Cell Carcinoma
Myron Arlen, Al Tsang, Joseph Scherrer, Joyce Wolf, Olga Saric
10 pages
DOI: 10.1615/CritRevImmunol.v21.i1-3.140
T-Cell Adoptive Therapy of Tumors: Mechanisms of Improved Therapeutic Performance
Liaomin Peng, Peter A. Cohen, Jorgen Kjaergaard, Gregory E. Plautz, James H. Finke, Gary K. Koski, Brian J. Czerniecki, Suyu Shu
34 pages
DOI: 10.1615/CritRevImmunol.v21.i1-3.150
A Unique Folate Hydrolase, Prostate-Specific Membrane Antigen (PSMA): A Target For Immunotherapy?
Jason Tasch, Mike Gong, Michel Sadelain, Warren D. W. Heston
13 pages
DOI: 10.1615/CritRevImmunol.v21.i1-3.160
Clinical Translation of Peptide-Based Vaccine Trials: The HER-2/neu Model
Mary L. Disis, Keith L. Knutson, Douglas G. McNeel, Donna Davis, Kathy Schiffman
11 pages
DOI: 10.1615/CritRevImmunol.v21.i1-3.170
Quantitating Therapeutically Relevant T-Cell Responses to Cancer Vaccines
Amy C. Hobeika, Timothy M. Clay, Paul J. Mosca, H. Kim Lyerly, Michael A. Morse
11 pages
DOI: 10.1615/CritRevImmunol.v21.i1-3.190
Overexpressed Cell Surface Interleukin-4 Receptor Molecules Can Be Successfully Targeted for Antitumor Cytotoxin Therapy
Koji Kawakami, Mariko Kawakami, Raj K. Puri
12 pages
DOI: 10.1615/CritRevImmunol.v21.i1-3.200

Critical Reviews™ in Immunology

Model for the recruitment of inducer-specific TNF-α gene enhanceosome in T lymphocytes., Vol. 29, Iss.2, Viral Mechanisms Involved in the TranscriptionalCBP/p300 Regulation of Inflammat..... Model for the recruitment of inducer-specific TNF-α gene enhanceosome in T lymphocytes., Vol. 29, Iss.2, Viral Mechanisms Involved in the TranscriptionalCBP/p300 Regulation of Inflammat..... Viral Mechanisms Involved in the Transcriptional CBP/р300 Regulation of Inflammatory and Immune Responses
Activation of several B cells is necessary for exosome release.Vol. 29, Iss. 3, Exosome Release by Primary B Cells. Activation of several B cells is necessary for exosome release.Vol. 29, Iss. 3, Exosome Release by Primary B Cells. Exosome Release by Primary B Cells
Homology model of human GrM. Vol. 29, Iss. 4, The Biology of Granzyme M: A Serine Protease with Unique Features. Homology model of human GrM. Vol. 29, Iss. 4, The Biology of Granzyme M: A Serine Protease with Unique Features. Biology of Granzyme M: A Serine Protease with Unique Features
(A) Gap-junction formation, (B) A three-dimensional collagen matrix Vol. 30, Iss. 6, Endothelial Cells as Key Determinants of the Tumor Microenvironment. (A) Gap-junction formation, (B) A three-dimensional collagen matrix Vol. 30, Iss. 6, Endothelial Cells as Key Determinants of the Tumor Microenvironment. Endothelial Cells as Key Determinants of the Tumor Microenvironment: Interaction with Tumor Cells, Extracellular Matrix and Immune Killer Cells
Biphasic HCV RNA decline after IFN treatment of chronic hepatitis C. Vol. 30, Iss. 2, Treatment of Hepatitis C Virus Infection with Interferon and Small Molecule Direct Antivirals. Biphasic HCV RNA decline after IFN treatment of chronic hepatitis C. Vol. 30,  Iss. 2, Treatment of Hepatitis C Virus Infection with Interferon and Small Molecule Direct Antivirals. Treatment of Hepatitis C Virus Infection With Interferon and Small Molecule Direct Antivirals: Viral Kinetics and Modeling